Clinical trial
Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or…
NCT00359333 · National Health Research Institutes, Taiwan, Other · Completed
Key facts
| NCT number | NCT00359333 |
|---|---|
| Title | Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Advanced/Metastatic Malignant GIST |
| Official title | Multiple Centers, Prospective, Phase II Trial of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Locally Advanced/Metastatic Soft Tissue Sarcoma or Imatinib Mesylate Refractory Advanced/Metastatic Malignant Gastrointestinal Stromal Tumor |
| Acronym | STS |
| Lead sponsor | National Health Research Institutes, Taiwan, Other |
| Collaborators | Mackay Memorial Hospital Tri-Service General Hospital China Medical University Hospital Kaohsiung Veterans General Hospital. Taichung Veterans General Hospital Buddhist Tzu Chi General Hospital |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma, Malignant Gastrointestinal Stromal Tumor |
| Intervention type | Drug |
| Interventions | Gemcitabine, Docetaxel |
| Enrollment | 58 |
| Start date | Dec 1, 2006 |
| Primary completion | Apr 1, 2010 |
| Completion | Mar 1, 2011 |
| First posted | Aug 2, 2006 |
| Last update posted | Oct 30, 2013 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: